Monthly Archives: February 2012

Autism Is Jim Calhoun's Biggest Opponent

Posted: Published on February 25th, 2012

Jim Calhoun, like many coaches, is superstitious. He might have a lucky tie or piece of jewelry he must wear to end a losing streak, or keep a winning streak going. But one item that remains in good times and bad is the blue puzzle piece he wears on the lapel of his suit jacket. The symbol for Autism Speaks, like the cause itself, remains close to his heart at all times. "He has never taken it off," Jeff Calhoun said. "I can't tell you how many people who have mentioned it to me — parents, families touched by autism, who tell me how much it means to them. He is very passionate about it. Just by lending his name and reaching out to people, he has done more than we could ever ask." Said Amy Calhoun: "When I see that blue pin on his lapel, it sometimes brings tears to my eyes. He is taking this on for Reese." The cause is a personal one for the Calhoun family. Jeff and Amy's daughter, Reese, now 8, was diagnosed at 2, and her grandfather's involvement with the advocacy group Autism Speaks is very deep. But because he is scheduled to … Continue reading

Comments Off on Autism Is Jim Calhoun's Biggest Opponent

Training parents is good medicine for children with autism behavior problems

Posted: Published on February 25th, 2012

Public release date: 24-Feb-2012 [ | E-mail | Share ] Contact: Karen N. Peart karen.peart@yale.edu 203-432-1326 Yale University Children with autism spectrum disorders who also have serious behavioral problems responded better to medication combined with training for their parents than to treatment with medication alone, Yale researchers and their colleagues report in the February issue of Journal of the American Academy of Child & Adolescent Psychiatry. "Serious behavioral problems interfere with everyday living for children and their families," said senior author on the study Lawrence Scahill, professor at Yale University School of Nursing and the Child Study Center. "Decreasing these serious behavioral problems results in children who are more able to manage everyday living." Scahill and his team completed a federally funded multi-site trial on 124 children ages 4 to 13 with autism spectrum disorders at three U.S. sites including Yale, Ohio State University, and Indiana University. In addition to autism spectrum disorders, children in the study had serious behavioral problems, including multiple and prolonged tantrums, aggression, and/or self-injurious behavior on a daily basis. The children in the study were randomly assigned to medication alone for six months or medication plus a structured training program for their parents for six … Continue reading

Comments Off on Training parents is good medicine for children with autism behavior problems

Meds for Autism Not Well Understood: Study

Posted: Published on February 25th, 2012

THURSDAY, Feb. 23 (HealthDay News) -- Children with autism may benefit from medications to treat children with attention-deficit hyperactivity disorder (ADHD) and other related disorders, but clearer guidelines are needed, a new study shows. Researchers analyzed data from more than 1,000 U.S. teens enrolled in special education programs, to assess the use of psychiatric medications in those with autism, ADHD and both conditions. Patients with both autism and ADHD had the highest rates of medicine use (about 58 percent), followed by those with ADHD only (around 49 percent) and those with autism only (about 34 percent), according to study author Paul Shattuck, an assistant professor at Washington University in St. Louis, and colleagues. Black teenagers with autism only or with autism and ADHD were less likely to receive medications than whites. "Observations from the present study reinforce the complexity of pharmacologic treatment of challenging behavior in kids with [autism spectrum disorders] and ADHD," Shattuck said in a university news release. "There needs to be a clearer guide for treating kids with both an [autism spectrum disorder] and ADHD." He noted that drug treatment for autism reflects a trial-and-error approach based on associated symptoms, and there is a poor understanding of … Continue reading

Comments Off on Meds for Autism Not Well Understood: Study

4 things to know about stroke

Posted: Published on February 25th, 2012

1. Don’t wait. Holland Hospital Dr. Sandip Kothari said the biggest problem with stroke is getting people to the hospital right away. “As soon as they notice some of the symptoms, they need to go to the emergency room. Don’t sleep on it, don’t call your third cousin who is a nurse,” he said. When it comes to chest pain and heart attacks, Kothari said people are trained to go right to the emergency room, so the American Heart Association piggy-backed off that same sense of urgency by referring to strokes as brain attacks. Liz Dirkse, a West Olive resident, suffered a stroke last March. She said she found herself flapping her arms to get her husband’s attention and alert him that something was wrong because she couldn’t speak. “Everything was right on the tip of my tongue, but my brain couldn’t tell my mouth what to do. It seemed that my brain had lost the connection to the rest of my body.” 2. Know the symptoms. Before her stroke, Dirkse knew symptoms varied from patient to patient, and her sudden inability to talk and walk tipped her off to what was happening. Kothari said the major symptoms to be … Continue reading

Comments Off on 4 things to know about stroke

Professor links body chemical to spinal cord injuries

Posted: Published on February 25th, 2012

Purdue researchers have discovered that a certain chemical in the body is the reason behind the worst parts of spinal cord injuries. Riyi Shi, professor of neuroscience and biomedical engineering, said spinal cord injuries of all kinds are made worse after the initial injury by a compound in the body. “The physical injury happens instantaneously, “ said Shi. “Secondary injury is mostly chemical based.” The compound that does all this damage has been dubbed “acrolein,” according to Shi. “We found out in most spinal cord injuries, this compound increases the injury by five or six times,” he said. Shi explained that acrolein increases the production of free radicals. A free radical is an atom that first loses an electron. The atom then tries to acquire another electron, stealing one from another atom. The atom that has an electron stolen also becomes a free radical. If this cycle goes unchecked, it can cause severe tissue damage as many atoms and molecules are destabilized and destroyed. “People first tried to treat spinal cord injury through removing free radicals,” Shi said, “but the acrolein just makes more of them.” Shi explained the reason for the body’s production of acrolein is unknown. “All we … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Professor links body chemical to spinal cord injuries

FDA Advisory Panel Recommends Approval of Chelsea's NORTHER(TM) (droxidopa) for the Treatment of Symptomatic …

Posted: Published on February 25th, 2012

CHARLOTTE, N.C., Feb. 23, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP - News) today announced that the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 7-4 with 1 abstention and 1 non-vote to recommend approval of NORTHERA(TM) (droxidopa) for the treatment of symptomatic neurogenic orthostatic hypotension (also known as Neurogenic OH or NOH) in patients with primary autonomic failure (Parkinson's disease, multiple system atrophy and pure autonomic failure), dopamine beta hydroxylase deficiency and non-diabetic autonomic neuropathy. "Chelsea is committed to improving the lives of patients with Neurogenic OH," commented Dr. Simon Pedder, president and CEO of Chelsea Therapeutics. "We believe our clinical data demonstrates the significant symptomatic benefit of Northera treatment across a broad range of Neurogenic OH symptoms. Since no other treatment has been proven to alleviate the symptoms of neurogenic OH or improve patients' ability to carry out activities of daily living, we continue to believe Northera could fill this unmet need for patients with Parkinson's disease, MSA, PAF and other neurologic diseases. We are pleased by today's panel vote and we look forward to continuing to work with the FDA in advance of the March 28, 2012 PDUFA action date." … Continue reading

Posted in Parkinson's Treatment | Comments Off on FDA Advisory Panel Recommends Approval of Chelsea's NORTHER(TM) (droxidopa) for the Treatment of Symptomatic …

Dance to support Shriners Hospital for Children

Posted: Published on February 25th, 2012

Select a Publication:   N E W S P A P E R S ---------------------------------------------- ---Alberta--- Airdrie - Airdrie Echo Banff - Banff Crag and Canyon Beaumont - Beaumont News Calgary - The Calgary Sun Camrose - Camrose Canadian Canmore - Canmore Leader Central Alberta - County Market Cochrane - Cochrane Times Cold Lake - Cold Lake Sun Crowsnest Pass - Crowsnest Pass Promoter Devon - Dispatch News Drayton - Drayton Valley Western Review Edmonton - Edmonton Examiner Edmonton - The Edmonton Sun Edson - Edson Leader Fairview - Fairview Post Fort McMurray - Fort McMurray Today Fort Saskatchewan - Fort Saskatchewan Record Grande Prairie - Daily Herald Tribune Hanna - Hanna Herald High River - High River Times Hinton - Hinton Parklander Lacombe - Lacombe Globe Leduc - Leduc Representative Lloydminster - Meridian Booster Mayerthorpe - Mayerthorpe Freelancer Nanton - Nanton News Peace Country - Peace Country Sun Peace River - Peace River Record Gazette Pincher Creek - Pincher Creek Echo Sherwood Park - Sherwood Park News Spruce Grove - Spruce Grove Examiner Stony Plain - Stony Plain Reporter Strathmore - Strathmore Standard Vermilion - Vermilion Standard Vulcan - Vulcan Advocate Wetaskiwin - Wetaskiwin Times Whitecourt - Whitecourt Star … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Dance to support Shriners Hospital for Children

Doctors: Dutch prince suffered grave brain damage

Posted: Published on February 25th, 2012

AMSTERDAM (AP) — A Dutch prince hit by an avalanche while skiing in Austria last week has suffered massive brain damage and may never regain consciousness, his doctors said Friday. Johan Friso, the second of Dutch Queen Beatrix's three sons, was buried for 25 minutes before rescuers found him. It then took nearly 50 minutes to resuscitate the prince after he was pulled from the snow, time that may have caused permanent damage, said Dr. Wolfgang Koller, head of trauma at the Innsbruck hospital where the prince is being treated. "It is clear that the oxygen starvation has caused massive brain damage to the patient," Koller said. "At the moment, it cannot be predicted if he will ever regain consciousness." The 41-year-old Friso, who is married and has two young daughters, will be moved later to a rehabilitation clinic for further treatment. But Koller cautioned it may take years before he awakens from his coma — if he ever does — and any recovery from such significant brain damage is a process of "months or even years." Friso was skiing off-trail in Lech, Austria, despite avalanche warnings, with a childhood friend from the alpine village. The Dutch royal family has … Continue reading

Posted in Brain Injury Treatment | Comments Off on Doctors: Dutch prince suffered grave brain damage

Judy's MS funding fight

Posted: Published on February 25th, 2012

Select a Publication:   N E W S P A P E R S ---------------------------------------------- ---Alberta--- Airdrie - Airdrie Echo Banff - Banff Crag and Canyon Beaumont - Beaumont News Calgary - The Calgary Sun Camrose - Camrose Canadian Canmore - Canmore Leader Central Alberta - County Market Cochrane - Cochrane Times Cold Lake - Cold Lake Sun Crowsnest Pass - Crowsnest Pass Promoter Devon - Dispatch News Drayton - Drayton Valley Western Review Edmonton - Edmonton Examiner Edmonton - The Edmonton Sun Edson - Edson Leader Fairview - Fairview Post Fort McMurray - Fort McMurray Today Fort Saskatchewan - Fort Saskatchewan Record Grande Prairie - Daily Herald Tribune Hanna - Hanna Herald High River - High River Times Hinton - Hinton Parklander Lacombe - Lacombe Globe Leduc - Leduc Representative Lloydminster - Meridian Booster Mayerthorpe - Mayerthorpe Freelancer Nanton - Nanton News Peace Country - Peace Country Sun Peace River - Peace River Record Gazette Pincher Creek - Pincher Creek Echo Sherwood Park - Sherwood Park News Spruce Grove - Spruce Grove Examiner Stony Plain - Stony Plain Reporter Strathmore - Strathmore Standard Vermilion - Vermilion Standard Vulcan - Vulcan Advocate Wetaskiwin - Wetaskiwin Times Whitecourt - Whitecourt Star … Continue reading

Posted in MS Treatment | Comments Off on Judy's MS funding fight

Saskatchewan starts to fill trial spots for controversial MS liberation therapy

Posted: Published on February 25th, 2012

REGINA - Saskatchewan multiple sclerosis patients hoping to take part in a clinical trial of a controversial treatment may soon get a call from the ministry of health. But only around 10 per cent of those who applied will actually get that call. Deb Jordan, a ministry spokeswoman, said 670 people had signed up as of Thursday. The deadline to apply for the two-year, double-blind trial of liberation therapy was midnight Friday. Jordan said names will be randomly drawn starting next week to determine who will fill 86 spots in the test taking place in Albany, N.Y. A successful candidate must be a Saskatchewan resident, under the age of 60 and not had liberation treatment. "Once we verify that information, then the applicant will be forwarded to the folks who are involved in the clinical trial," said Jordan. "I want to also emphasize that the fact that a patient may be drawn does not necessarily mean that they will move on to the clinical trial. "There's the medical assessment that has to take place by the team and it is the ... clinical team that is operating the clinical trial that will ultimately make the decisions about the patients who … Continue reading

Posted in MS Treatment | Comments Off on Saskatchewan starts to fill trial spots for controversial MS liberation therapy